Clinical Trial: Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07672626) titled 'Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster' on June 23.

Brief Summary: Rabies is caused by rabies virus with a 100% mortality rate in humans. Most of cases occur in Africa and Asia, mainly in underserved populations. Rabies is a vaccine-preventable disease in both humans and animals. Over the years, the Vero cell rabies vaccine has been recognized by the World Health Organization (WHO) and the European Union, and is widely used globally. Currently, one of the post-exposure prophylaxis (PEP) regimens recommended by the World Health Organization (WHO) is the five-dose "Essen" regimen ...